Elevation Wealth Partners’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8K | Buy |
202
+114
| +130% | +$6.08K | ﹤0.01% | 364 |
|
|
2025
Q1 | $3.56K | Buy |
88
+28
| +47% | +$1.13K | ﹤0.01% | 423 |
|
|
2024
Q4 | $1.67K | Hold |
60
| – | – | ﹤0.01% | 441 |
|
|
2024
Q3 | $1.72K | Hold |
60
| – | – | ﹤0.01% | 425 |
|
|
2024
Q2 | $1.41K | Hold |
60
| – | – | ﹤0.01% | 460 |
|
|
2024
Q1 | $1.52K | Buy |
60
+50
| +500% | +$1.26K | ﹤0.01% | 422 |
|
|
2023
Q4 | $506 | Hold |
10
| – | – | ﹤0.01% | 413 |
|
|
2023
Q3 | $506 | Hold |
10
| – | – | ﹤0.01% | 311 |
|
|
2023
Q2 | $467 | Hold |
10
| – | – | ﹤0.01% | 324 |
|
|
2023
Q1 | $383 | Buy |
+10
| New | +$383 | ﹤0.01% | 325 |
|